Deletion of Dot1l leads to pancytopenia and bone marrow hypocellularity. (A) H3K79me2 Western blot of bone marrow. Unfractionated bone marrow was harvested from Dot1lF/F;CreER− or Dot1lwt/wt;CreER+ (Dot1l+/+) and Dot1lF/F;CreER+ (Dot1lF/F) mice 3 weeks after tamoxifen injection. Dot1l deletion led to the loss of H3K79 methylation in Dot1lF/F bone marrow. Histone 3 blot was used as loading control. (B) Survival curve of mice after Dot1l deletion. Dot1l+/+ and Dot1lF/F mice were injected with tamoxifen once a month for continuous Dot1l deletion. Dot1lF/F mice died between 8 to 12 weeks after initial injection. (C) Hematoxylin and eosin-stained section of bone marrow. Dot1l deletion led to bone marrow hypocellularity in Dot1lF/F mice. Tissues were collected when Dot1lF/F mice became moribund. Scale bars represent 50μm. Micrographs were obtained using Olympus BX41 microscope, 100×/1.30 oil UPlanFL N lens, and Olympus DP71 camera. (D) Final complete blood counts before Dot1lF/F mice died or were sacrificed. Data points represent individual animals. Bars represent mean values.